生物活性 | |||
---|---|---|---|
描述 | HCV-IN-31 exhibits an EC50/EC95 of 15.7 μM for HCV replicon inhibition [1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.20mL 0.64mL 0.32mL |
16.01mL 3.20mL 1.60mL |
32.02mL 6.40mL 3.20mL |
参考文献 |
---|